Skip to content

Efficacy of Low-Intensity Laser Acupoint Irradiation in the Treatment of Temporomandibular Joint Disorder: A Randomized Single-Blind Clinical Study

Efficacy of Low-Intensity Laser Acupoint Irradiation in the Treatment of Temporomandibular Joint Disorder: A Randomized Single-Blind Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000301
Enrollment
Unknown
Registered
2025-02-16
Start date
2025-03-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

temporomandibular joint disorder

Interventions

Group A (control group):Laser irradiation of localized discomfort
Group B (experimental group):Local + acupoint laser irradiation

Sponsors

Yichang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria of DC/TMD, with primary symptoms including restricted mouth opening or functional limitation, and pain, clicking, or popping in the masticatory muscles and/or temporomandibular joint during biting or jaw movement; (2) Aged between 18 and 70 years old, able to cooperate with treatment and examinations; (3) NRS score = 3 points; (4) The patient voluntarily participates in this clinical trial, commits to completing the entire treatment process, and signs the informed consent form. All of the above criteria must be "yes" to be eligible for the trial.

Exclusion criteria

Exclusion criteria: 1. patients with bone abnormalities of the jaws (proof of imaging is required) such as temporomandibular joint disease or rheumatoid arthritis; 2. Patients with other primary medical conditions that clearly cause pain or anxiety and depression and require prompt treatment; 3. Suffer from other serious illnesses such as various systemic diseases and diseases of various systems; 4. Those who have received any form of analgesic or anxiolytic treatment within the past 2 weeks; 5. Patients with mental illness; 6. Patients who have received any form of TMD treatment within the last month; 7. inability to understand and complete the various scales to be filled out. 8. Those who in the opinion of the study physician and the project leader are not suitable for participation in this experiment. The above choices must be "No" in order to participate in the trial.

Design outcomes

Primary

MeasureTime frame
numerical rating scale(NRS); maximum mouth opening;

Secondary

MeasureTime frame
hospital anxiety and depression scale (HADS);insomnia severity index (ISI);

Countries

China

Contacts

Public ContactAnfeng Xiang

Yichang Hospital of Traditional Chinese Medicine

afxiang0101@163.com+86 159 7166 7172

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026